S&P 500   3,449.60 (+0.41%)
DOW   28,342.58 (+0.47%)
QQQ   283.80 (-0.14%)
AAPL   115.70 (-1.00%)
MSFT   214.36 (-0.20%)
FB   277.10 (-0.58%)
GOOGL   1,602.85 (+1.06%)
AMZN   3,158.22 (-0.84%)
TSLA   431.28 (+2.04%)
NVDA   535.16 (-1.08%)
BABA   306.09 (-0.61%)
CGC   19.82 (+1.69%)
GE   7.66 (+4.64%)
MU   54.46 (+2.16%)
AMD   79.76 (+0.71%)
T   28.22 (+5.61%)
F   8.08 (+2.93%)
ACB   4.74 (-2.27%)
GILD   60.01 (-0.33%)
NFLX   483.59 (-1.12%)
BA   167.98 (+2.51%)
NIO   27.20 (-2.37%)
DIS   127.55 (+0.73%)
S&P 500   3,449.60 (+0.41%)
DOW   28,342.58 (+0.47%)
QQQ   283.80 (-0.14%)
AAPL   115.70 (-1.00%)
MSFT   214.36 (-0.20%)
FB   277.10 (-0.58%)
GOOGL   1,602.85 (+1.06%)
AMZN   3,158.22 (-0.84%)
TSLA   431.28 (+2.04%)
NVDA   535.16 (-1.08%)
BABA   306.09 (-0.61%)
CGC   19.82 (+1.69%)
GE   7.66 (+4.64%)
MU   54.46 (+2.16%)
AMD   79.76 (+0.71%)
T   28.22 (+5.61%)
F   8.08 (+2.93%)
ACB   4.74 (-2.27%)
GILD   60.01 (-0.33%)
NFLX   483.59 (-1.12%)
BA   167.98 (+2.51%)
NIO   27.20 (-2.37%)
DIS   127.55 (+0.73%)
S&P 500   3,449.60 (+0.41%)
DOW   28,342.58 (+0.47%)
QQQ   283.80 (-0.14%)
AAPL   115.70 (-1.00%)
MSFT   214.36 (-0.20%)
FB   277.10 (-0.58%)
GOOGL   1,602.85 (+1.06%)
AMZN   3,158.22 (-0.84%)
TSLA   431.28 (+2.04%)
NVDA   535.16 (-1.08%)
BABA   306.09 (-0.61%)
CGC   19.82 (+1.69%)
GE   7.66 (+4.64%)
MU   54.46 (+2.16%)
AMD   79.76 (+0.71%)
T   28.22 (+5.61%)
F   8.08 (+2.93%)
ACB   4.74 (-2.27%)
GILD   60.01 (-0.33%)
NFLX   483.59 (-1.12%)
BA   167.98 (+2.51%)
NIO   27.20 (-2.37%)
DIS   127.55 (+0.73%)
S&P 500   3,449.60 (+0.41%)
DOW   28,342.58 (+0.47%)
QQQ   283.80 (-0.14%)
AAPL   115.70 (-1.00%)
MSFT   214.36 (-0.20%)
FB   277.10 (-0.58%)
GOOGL   1,602.85 (+1.06%)
AMZN   3,158.22 (-0.84%)
TSLA   431.28 (+2.04%)
NVDA   535.16 (-1.08%)
BABA   306.09 (-0.61%)
CGC   19.82 (+1.69%)
GE   7.66 (+4.64%)
MU   54.46 (+2.16%)
AMD   79.76 (+0.71%)
T   28.22 (+5.61%)
F   8.08 (+2.93%)
ACB   4.74 (-2.27%)
GILD   60.01 (-0.33%)
NFLX   483.59 (-1.12%)
BA   167.98 (+2.51%)
NIO   27.20 (-2.37%)
DIS   127.55 (+0.73%)
Log in
LON:SKP

SkyePharma Share Forecast, Price & News

Add
Today's Range N/A
50-Day Range
£121.50
MA: £121.78
£124.30
52-Week Range N/A
Volume22,547 shs
Average Volume177,955 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Skyepharma Ltd, formerly Skyepharma PLC, is a drug delivery company engaged in the development of oral and inhalation products. The Company operates as an independent developer of complex pharmaceutical products for global markets. Its principal activities are the generation and development of product and drug delivery technology concepts, involving the application of its inhalation and oral technologies. It operates through the segment of development and supply of pharmaceutical products. It is also involved in the supply of products to its marketing partners, as in the case for flutiform and over seven oral products manufactured in its Lyon Facility. It operates primarily for respiratory applications. Its inhalation products include Relvar Ellipta/Breo Ellipta, Anoro Ellipta and Incruse Ellipta. Its oral products include RAYOS/LODOTRA, Requip Once-a-day, Xatral/Uroxatral, Madopar DR/Prolopa, Sular, ZYFLO CR, Paxil CR, Diclofenacratiopharm Uno, Triglide and Coruno.
Read More
SkyePharma logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 1.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.34 out of 5 stars

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
CUSIPN/A
CIKN/A
WebN/A
Phone+44-20-78810524
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable
30 days | 90 days | 365 days | Advanced Chart

Receive SKP News and Ratings via Email

Sign-up to receive the latest news and ratings for SKP and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











SkyePharma (LON:SKP) Frequently Asked Questions

What other stocks do shareholders of SkyePharma own?

What is SkyePharma's stock symbol?

SkyePharma trades on the London Stock Exchange (LON) under the ticker symbol "SKP."

How do I buy shares of SkyePharma?

Shares of SKP and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

How can I contact SkyePharma?

SkyePharma's mailing address is 46-48 Grosvenor Gardens, LONDON, SW1W 0EB, United Kingdom. The company can be reached via phone at +44-20-78810524.

This page was last updated on 10/22/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.